List of Oncternal Therapeutics patents

List of Oncternal Therapeutics patents

List of Japan Display patents

List of Weinberg Medical Physics LLC patents

List of Iron Mountain (company) patents

List of funding rounds for Icon Build

List of companies in Peak Valley Capital's investment portfolio

Patents where

Current Assignee

Name

is

Oncternal Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11285132 Uses of indolinone compounds	Patent 11285132 was granted and assigned to Oncternal Therapeutics on March, 2022 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	11285132	March 29, 2022
	‌ US Patent 10159660 Uses of indolinone compounds	Patent 10159660 was granted and assigned to Oncternal Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	10159660	December 25, 2018
	‌ US Patent 10646470 Uses of indolinone compounds		Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	10646470	May 12, 2020
	‌ US Patent 10351569 Indoline analogs and uses thereof	Patent 10351569 was granted and assigned to Oncternal Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	10351569	July 16, 2019
	‌ US Patent 9822122 Indoline analogs and uses thereof	Patent 9822122 was granted and assigned to Oncternal Therapeutics on November, 2017 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	9822122	November 21, 2017
	‌ US Patent 9604927 Indolinone compounds and uses thereof	Patent 9604927 was granted and assigned to Oncternal Therapeutics on March, 2017 by the United States Patent and Trademark Office.		Oncternal Therapeutics		United States Patent and Trademark Office	9604927	March 28, 2017
	‌ US Patent 9987251 Indolinone compounds and uses thereof	Patent 9987251 was granted and assigned to Oncternal Therapeutics on June, 2018 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	9987251	June 5, 2018
	‌ US Patent 9895352 Indolinone compounds and uses thereof	Patent 9895352 was granted and assigned to Oncternal Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	9895352	February 20, 2018
	‌ US Patent 10711008 Indoline analogs and uses thereof		Oncternal Therapeutics	Oncternal Therapeutics		United States Patent and Trademark Office	10711008	July 14, 2020
	‌ US Patent 10849873 Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy	Patent 10849873 was granted and assigned to Oncternal Therapeutics on December, 2020 by the United States Patent and Trademark Office.	‌ Gtx, Inc.	Oncternal Therapeutics		United States Patent and Trademark Office	10849873	December 1, 2020

10 results

0 selected

10 results

0 selected